Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • PharmaTutor
    7 June 2010

    New standard care of Advanced Melanoma presented in ASCO 2010 annual meeting

    June 6, 2010 (Chicago, Illinois) — An experimental therapy for advanced melanoma has been shown to improve overall survival in patients, and is "on the road" to becoming the "new standard of care," said one of its investigators here at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting.

  • 7 June 2010
    Karnataka pharma majors bullish over European export prospects

    Liquidity crunch and growing uncertainty in the Euro zone have not deterred the Karnataka-based pharma companies from expanding their operations and also patent filing in Europe.

    [adsense:336x280:8701650588]

  • 7 June 2010
    ICMR to launch task force projects on burden of rotavirus diarrhoea in India

    Aiming to understand the potential health benefits of rotavirus vaccination and also to develop a national representative data on rotavirus burden and strains in India, the Indian Council of Medical Research (ICMR) will soon embark on task force projects on burden of rotavirus diarrhoea in India under the Indian Rotavirus Surveillance Network.

  • 10 May 2010
    AIDS Control Dept fails to achieve physical target even after utilising 98 % of allocation

    Although the department of AIDS Control under the Union health ministry has exhausted its allocation almost completely, it failed to achieve the physical targets set for the last financial year.

  • 10 May 2010
    US FDA to review once-weekly treatment for type 2 diabetes Bydureon in October

    Amylin Pharmaceuticals, Inc, Eli Lilly and Company and Alkermes, Inc announced that the US Food and Drug Administration (FDA) has classified the Bydureon (exenatide for extended-release injectable suspension) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010.

  • 10 May 2010
    Zilver Peripheral Stent Proves Durable

    The Zilver PTX (Cook Medical, Bloomington, IN) polymer-free paclitaxel-eluting peripheral stent shows near-perfect two-year durability and safety in a nonrandomized study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2010 Scientific Sessions in San Diego [1].

  • 30 April 2010
    ICRI ties up with South Carolina Medical University to offer masters in Health Administration-Global

    After the approval of the Foreign Universities Bill by the government, ICRI, the pioneers in healthcare and clinical research education, has entered into an academic/strategic alliance with Medical University of South Carolina (MUSC) to offer Masters in Health Administration-Global. Eminent faculty and administrative staff of MUSC were present during the launch.

  • 30 April 2010
    GSK gets clean chit from DCGI for running cervical cancer vaccine ads in media

    The multinational drug company GlaxoSmithKline (GSK), which had run an advertisement blitzkrieg in several national newspapers in the country on cervical cancer vaccine late last year in gross violation of Drugs and Cosmetics Act, 1940 and Drugs and Magical Remedies Act 1954, has been completely absolved of any irregularities by the drug controller general of India (DCGI) Dr Surinder Singh, it is learnt.

  • 30 April 2010
    Deep Brain Stimulation Improves Quality of Life in Advanced Parkinson's

    In a randomized, multicenter study of advanced Parkinson's disease (PD) patients, those treated with deep brain stimulation (DBS) of the subthalamic nucleus combined with best medical therapy had better self-reported quality of life at 1 year than those treated with best medical therapy alone.

  • 30 April 2010
    Long-Term Use of Anabolic Steroids Associated With Reduced LV Ejection Fraction

    April 29, 2010 (Boston, Massachusetts) — Long-term users of anabolic androgenic steroids have a high risk of developing cardiac dysfunction, which may be severe enough to increase the risk of heart failure, a new study suggests [1].

    The study, published online April 27, 2010 in Circulation: Heart Failure, was conducted by a group led by Dr Aaron Baggish (Massachusetts General Hospital, Boston, MA).

    [adsense:336x280:8701650588]

Subscribe to Pharma News